IBD Biologics in Dubai: What’s Changed Going Into 2026 (Crohn’s & UC Patients)

Описание: As we approach 2026, many patients with Crohn’s disease and ulcerative colitis in Dubai are asking the same question:
“I feel well on my biologic, but is that enough?”
After more than 25 years caring for people with inflammatory bowel disease, I’ve seen a major shift in how biologic treatments are used.

In the past, if symptoms improved, we often assumed the medication was working. Today, we know that long-term control requires a more precise, proactive approach.

In this video, I explain how biologic treatment for IBD has changed, why monitoring inflammation matters even when you feel well, and how the modern goal is deep remission — not just symptom relief.

This approach helps biologics last longer, reduces flares, and improves long-term stability.

This video is particularly relevant if you are currently taking biologics such as infliximab, adalimumab, ustekinumab, vedolizumab, or newer IL-23 or JAK-inhibitor therapies, and want to understand how IBD care is evolving in Dubai.

I am a UK-trained gastroenterologist in Dubai with a special interest in Crohn’s disease, ulcerative colitis, and long-term biologic management.